Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Are you Dr. Elimova?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Elena Elimova, MD is an oncologist in Houston, Texas. She is currently licensed to practice medicine in Texas.
Education & Training
Memorial University of Newfoundland FOMClass of 2008
Certifications & Licensure
TX State Medical License 2014 - 2024
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- The tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancer.Abdul R Farooq, Amy X Zhang, Michelle Chan-Seng-Yue, James T Topham, Grainne M O'Kane
NPJ Precision Oncology. 2025-04-04 - Eastern Canadian Gastrointestinal Cancer Consensus Conference 2024.Jennifer Leigh, Arwa Ahmed, Francine Aubin, Scott Berry, Melanie Boucher
Current Oncology. 2025-03-18 - Ramucirumab and paclitaxel in second or greater lines of therapy in patients with HER2-positive gastroesophageal cancer: a single center study.Yvonne Bach, Divya Sharma, Hiroko Aoyama, Lucy X Ma, Carly C Barron
The Oncologist. 2025-03-10
Press Mentions
Astellas Receives Health Canada Approval for VYLOY® (Zolbetuximab) in Combination with Chemotherapy for Advanced Gastric and Gastroesophageal Junction CancerJanuary 9th, 2025- Jazz Swings on ASCO-GI Data for ZanidatamabJanuary 23rd, 2023
- First-Line Zanidatamab Plus Chemotherapy for Her2-Expressing Metastatic Gastroesophageal AdenocarcinomaJanuary 20th, 2023
- Join now to see all
